One tactic cancer cells and stage 4 cancers employ
to develop and progress is by avoiding programmed cell death
(apoptosis.) In a normal body, apoptosis is the naturally-occurring
process by which the body maintains healthy tissue function by disposing
of damaged cells. It is triggered by signals, including cell stress and
DNA damage.
In many cancer patients, we see the process of apoptosis averted. This
allows cancer cells to continue to endure. In a healthy person, we may
see apoptosis protect us from potential cancer situations up to 10,000
times per day; so what we must ask ourselves is “why then do stage 4
cancer patients divert this natural process?”
Mutations Bring About Stubborn and Resistant Stage 4 Cancers
Both internal and external cellular triggers can commence apoptosis. To
catalyze internally, the process relies on protein p53. In the event of
certain mutations to this protein’s gene, the protein can become
inactive, thereby inhibiting internally-triggered apoptosis
functionality. This mutation is seen in up to 50 percent of all human
cancers. By targeting this mutation, cancer treatments are enhanced
significantly.
Stage 4 Cancers May Dodge Chemotherapy
It is common knowledge that radiation’s and chemotherapy’s ability to
damage cell DNA, indirectly promotes apoptosis. However, cancer takes
advantage of a tricky loophole to side-step what should be imminent
trouble for its cells. As mutations to protein p53 can shut down
apoptosis from within the cell, in such circumstance, cancer cells can
escape the harm of conventional stage 4 treatments meant to wipe it out.
Because Envita has seen this repeatedly over the last decade plus of
working with the most difficult cancers, we have become proactive. Our
protocols call for preventative treatments designed to overcome p53
oncogene mutations through specialized nutrition, and encouraging
healthy apoptosis.
Recognizing that nutritional, immunological, or impairments in toxin
elimination deficiencies can create cancer-friendly environments is the
first step. Taking action against the causes of these environments is
what sets Envita apart.
Launching an Offensive on Cancer
By simultaneously catalyzing apoptosis outside and within the cell, it
is possible to destroy cancer cells that were previously deemed
conventional treatment-resistant. Depending upon the stage and cancer
type, Envita has a variety of treatments to support mitochondria
dysfunction – coupled with nutrients employed to restore healthy
functionality. These unique treatments are a part of why Envita has such
and impressive track record against advanced and stage 4 cancers.
Treatment Improved – Results Achieved
Envita’s Comprehensive Smart Oncology®(link to Envita cancer section)
program integrates successful oncology combinations with our aggressive
natural therapies that affect apoptosis in cancer cells by using tumor
destruction methods that actually rely solely on p53. Visit our PPMR
process( link to Envita home or ppmr) or contact us speak to one of our
patient-care educators so that we can put an immediate plan in place for
you.
Article Source: http://www.compensationsecrets.co.uk/